To Evaluate Safety, Tolerability and Pharmacological Effects of PU AD in Subjects With Mild AD Dementia
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04311515 |
|
Recruitment Status :
Terminated
(Samus Therapeutics company closure)
First Posted : March 17, 2020
Last Update Posted : November 17, 2022
|
Sponsor:
Samus Therapeutics, Inc.
Information provided by (Responsible Party):
Samus Therapeutics, Inc.
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Terminated |
|---|---|
| Actual Primary Completion Date : | September 9, 2020 |
| Actual Study Completion Date : | November 15, 2022 |